Research location
A Coruña
La Coruña, Spain
Advertisement
Research activity in A Coruña
La Coruña, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 125 trials and 127 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in A Coruña
68 linked trials · page 1 of 2PALACE: Cemiplimab Trial According to ctDNA LevelsNCT06917573 · 2025-07-29 · 1 site observation
RECRUITING
Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)NCT07153445 · 2025-07-08 · 1 site observation
RECRUITING
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.NCT06431633 · 2025-02-04 · 1 site observation
RECRUITING
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorNCT06472245 · 2024-12-03 · 1 site observation
RECRUITING
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second TrimestersNCT06716242 · 2024-12-02 · 1 site observation
RECRUITING
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC PatientsNCT06634199 · 2024-10-03 · 1 site observation
RECRUITING
Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)NCT06055504 · 2023-09-06 · 1 site observation
RECRUITING
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapyNCT05398094 · 2022-03-21 · 1 site observation
RECRUITING
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)NCT05973773 · 2023-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Characteristics of Sexual Dysfunction in Patients With Lung CancerNCT06018376 · 2023-07-13 · 1 site observation
COMPLETED
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE TrialNCT05569811 · 2022-11-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung CancerNCT05384015 · 2022-11-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic SubtypeNCT05207709 · 2022-03-28 · 1 site observation
TERMINATED
Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use TreatmentNCT05167500 · 2021-12-09 · 2 site observations
COMPLETED
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.NCT04990284 · 2021-11-29 · 1 site observation
COMPLETED
Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain MetastasesNCT05012254 · 2021-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural MesotheliomaNCT05005429 · 2021-09-20 · 1 site observation
COMPLETED
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)NCT04776447 · 2021-06-16 · 1 site observation
COMPLETED
Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast CancerNCT04759248 · 2021-03-15 · 1 site observation
ACTIVE_NOT_RECRUITING
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapyNCT04564157 · 2021-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated PatientsNCT04512430 · 2020-12-02 · 1 site observation
TERMINATED
Registry Study of Pregnancy and Breast CancerNCT04603820 · 2019-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206NCT04009122 · 2019-06-11 · 1 site observation
COMPLETED
NADIM II: Neo-Adjuvant ImmunotherapyNCT03838159 · 2019-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Atezolizumab Plus Bevacizumab in First Line NSCLC PatientsNCT03836066 · 2019-05-15 · 1 site observation
COMPLETED
Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positiveNCT03790397 · 2019-02-26 · 1 site observation
COMPLETED
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]NCT03734029 · 2018-12-27 · 1 site observation
COMPLETED
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]NCT03529110 · 2018-08-09 · 1 site observation
COMPLETED
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]NCT03523585 · 2018-08-01 · 1 site observation
COMPLETED
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLCNCT03041311 · 2017-06-29 · 1 site observation
COMPLETED
Nivolumab in the Real World: Analysis of the Expanded Use in Spanish PatientNCT03132493 · 2017-06-01 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyNCT03078036 · 2017-03-13 · 1 site observation
COMPLETED
Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid ArthritisNCT02087696 · 2014-05-01 · 1 site observation
UNKNOWN
Hepatocellular Carcinoma in HIV-infected PatientsNCT02785835 · 2014-05-01 · 1 site observation
COMPLETED
A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid ArthritisNCT01995201 · 2013-09-01 · 1 site observation
COMPLETED
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of IllnessNCT01959659 · 2013-05-01 · 1 site observation
COMPLETED
A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid ArthritisNCT01772316 · 2012-12-01 · 1 site observation
COMPLETED
An Observational Study in Clinical Practice Management of Patients With Biological Drugs in MonotherapyNCT01664117 · 2012-06-01 · 1 site observation
COMPLETED
An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)NCT01512420 · 2011-11-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed TherapyNCT01419197 · 2011-09-01 · 1 site observation
COMPLETED
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid ArthritisNCT01462162 · 2011-09-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT01399697 · 2011-09-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-InhibitorNCT01283971 · 2011-05-01 · 1 site observation
TERMINATED
Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast CancerNCT01186991 · 2011-03-01 · 1 site observation
COMPLETED
An Non-Interventional Study of Patients With Persistent Symptoms of SchizophreniaNCT01634542 · 2011-02-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid ArthritisNCT01225393 · 2010-11-01 · 1 site observation
COMPLETED
An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)NCT01338545 · 2010-07-01 · 1 site observation
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease InhibitorNCT01166477 · 2010-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.